Literature DB >> 672143

25-hydroxy-vitamin D levels in a patient with hypervitaminosis D.

H v Lilienfeld-Toal, W Messerschmidt, B Sturm, H Ochs.   

Abstract

We measured the concentrations of serum calcium and 25-hydroxy-vitamin D in a patient with hypervitaminosis D during 3 months of therapy directed toward correcting the hypercalcemia. Serum calcium could not be maintained at normal concentration without specific therapy until 9 weeks after vitamin D was discontinued. Concentration of 25-hydroxy-vitamin D at the time was 285 ng/ml, approximately half of the value measured three weeks after withdrawal of vitamin D. Serial measurements of the concentration of 25-hydroxy-vitamin D seem to be a useful means of assessing the degree of intoxication in patients with hypervitaminosis D.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 672143     DOI: 10.1007/BF02429107

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Protracted vitamin D intoxication.

Authors:  K R Shetty; K Ajlouni; P S Rosenfled; T C Hagen
Journal:  Arch Intern Med       Date:  1975-07

2.  A rapid assay for 25-OH-vitamin D3 without preparative chromatography.

Authors:  R E Belsey; H F DeLuca; J T Potts
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

3.  Competitive protein-binding radioassay for 25-hydroxycholecalciferol.

Authors:  J G Haddad; K J Chyu
Journal:  J Clin Endocrinol Metab       Date:  1971-12       Impact factor: 5.958

4.  The metabolism of vitamin D3 and 25-hydroxyvitamin D3 in normal and anephric humans.

Authors:  R W Gray; H P Weber; J H Dominguez; J Lemann
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

5.  The metabolism of isotopically labelled vitamin D3 in man: the influence of the state of vitamin D nutrition.

Authors:  E B Mawer; K Schaefer; G A Lumb; S W Stanbury
Journal:  Clin Sci       Date:  1971-01       Impact factor: 6.124

6.  25-hydroxycholecalciferol. The probable metabolically active form of vitamin D3: its identification and subcellular site of action.

Authors:  H F DeLuca
Journal:  Arch Intern Med       Date:  1969-10

7.  Pharmacokinetics of 5,6-trans-25-hydroxycholecalciferol, a synthetic analogue of vitamin D3, in man.

Authors:  G Offermann; K Schaefer; H G Grigoleit; F Dittmar
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

8.  Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.

Authors:  M R Hughes; D J Baylink; P G Jones; M R Haussler
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

9.  [Observations in vitamin D and dihydrotachysterol poisoning].

Authors:  R Ziegler; H Minne; F Raue; G Paar; G Delling
Journal:  Dtsch Med Wochenschr       Date:  1975-02-28       Impact factor: 0.628

10.  [Fatal vitamin D intoxication].

Authors:  F Laubenthal; M Reichenberger; D Reinwein
Journal:  Dtsch Med Wochenschr       Date:  1975-02-28       Impact factor: 0.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.